SuspendedNot Applicable

Patients' Attitudes Toward and Experiences With Buprenorphine Treatment

Stopped: Study completed Phase 1 before funding ended.

United States817 participantsStarted 2021-11-20

Plain-language summary

This study will disseminate five surveys collecting individual's attitudes and experiences during buprenorphine treatment for Opioid Use Disorder during the COVID-19 pandemic.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants must be 18 years of age or older. * Participants report currently having a legal prescription for buprenorphine for opioid use disorder. * Participants must have a past or present opioid use disorder. * Participants must currently reside in the state of Massachusetts. * Participants must be able to comprehend the English language. Exclusion Criteria: * Unable to complete an online survey. * Unable to complete a verification step that ensures bots are not used to complete survey. * Complete a survey with no variation suggesting they did not read the survey.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient's Experiences with Office-Based Opioid Treatment

Timeframe: Day 1

Reasons for Abstaining from Opioids Questionnaire

Timeframe: Day 1

Patients' Attitudes Toward the Use of Cannabis During Office-Based Opioid Treatment

Timeframe: Day 1

Patients' Attitudes Toward the Use of Cigarettes/E-Cigarettes During Office-Based Opioid Treatment

Timeframe: Day 1

Patients' Attitudes Toward and Experiences with the Use of Benzodiazepines during Office-Based Opioid Treatment

Timeframe: Day 1

Trial details

NCT IDNCT05121428

SponsorCambridge Health Alliance

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-20

View on ClinicalTrials.gov More Opioid-use Disorder trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Patient's Experiences with Office-Based Opioid Treatment

Timeframe: Day 1

Reasons for Abstaining from Opioids Questionnaire

Timeframe: Day 1

Patients' Attitudes Toward the Use of Cannabis During Office-Based Opioid Treatment

Timeframe: Day 1

Patients' Attitudes Toward the Use of Cigarettes/E-Cigarettes During Office-Based Opioid Treatment

Timeframe: Day 1

Patients' Attitudes Toward and Experiences with the Use of Benzodiazepines during Office-Based Opioid Treatment

Timeframe: Day 1